Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
62 results about "Blood ammonia" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Blood ammonia comes primarily from the bacterial breakdown of unabsorbed dietary protein in the intestine. Intestinal ammonia passes into the bloodstream and travels to the liver, which converts ammonia into urea.
Blood ammonia content determination method and blood ammonia diagnosis kit
InactiveCN1769481AStrong specificityLess susceptible to interferenceMicrobiological testing/measurementLactate dehydrogenaseMedical testing
The invention relates to a method for determining the content of blood ammonia, and also the reagent kit for blood ammonia diagnosis. The reagent kit comprises cushioning solution, adenosine triphosphate, phosphoenolpyruvate phosphatase, deacidized type coenzyme, ammonia kinase, pyruvate kinase, lactate dehydrogenase, and stabilizer. By mixing sample and reagent of a predetermiend volumetric ratio, generating coupling reaction between them, subjecting the final reactant to biochemiscal analyser, the main wavelength absorbancy variance ratio (speed) can be detected, and the blood ammonia content can thus be measured. The method of the invention can be used to obtain the needed measurement result purely through biochemical analytic instruments, and advantages of the method include higher sensibility, better accuracy, less susceptibility to contamination of internal or external materials, and easy application.
Owner:王尔中
Determination of blood ammonia content and blood ammonia diagnostic reagent kit
InactiveCN1778963AStrong specificityImprove test accuracyMicrobiological testing/measurementBlood ammoniaChemistry
The invention is about a method of measuring the content of blood ammonia, and it also concerns the reagent box of blood ammonia diagnosis. This invention belongs to the field of medical testing and measuring technology. The reagent box is consisted of buffer solution, 2ú¡ketoglutarate, reduced coenzyme, adenosine triphosphate, phosphoenolpyruvate, glutamate dehydrogenase, glutamate kinase, pyruvate kinase, lactate dehydrogenase and stabilizer. Firstly, we cause an enzyme-coupled reaction through mixing the sample and the reagent according to a certain proportion of volume; secondly, put the final reactant under the biochemical analyzer and test the absorbance variational situation (speed) of dominant wavelength; then we can get the content of blood ammonia. By using this invention, we can get the necessary measuring result with high sensitiveness and fine precision through biochemical analyzer, and the result would not be contaminated by material of internal and exogenous sources. Thus, this method can be conveniently promoted and applied.
Owner:SUZHOU ANJ BIOTECHNOLOGY CO LTD
Method for detecting blood ammonia content and blood ammonia diagnostic reagent kit
InactiveCN1749756AStrong specificityImprove test accuracyColor/spectral properties measurementsBiological testingAdenosinePeroxidase
The present invention belongs to the field of medical detection technology. The reagent kit for blood ammonia diagnosis includes buffering solution, adenosine triphophate, glutamic acid, pyruvic acid, alcohol, oxidized coenzyme, glutamine synthetase, pyruvate oxidase, hydrogen peroxidase, aldehyde dehydrogenase and stabilizer. Through mixing the sample and reagent in certain volume ratio to produce enzyme coupling reaction, and detecting in biochemical analyzer the main wavelength absorbency change speed, the blood ammonia content is measured. The present invention can obtain the measurement result in biochemical analyzer in high sensitivity, high precision and no contamination of various foreign and internal matters.
Owner:王尔中
Multiple organ dysfunction and support system
ActiveCN101041092ARemove inflammatory mediatorsEliminate endotoxinOther blood circulation devicesDialysis systemsOrgan dysfunctionOxygen
The invention discloses a multiple organ function support system, formed by a body, an external blood circuit, a plasma separating-adsorbing circuit, an albumin circuit, a dialysate circuit, a feeding circuit and an operating system. The invention can eliminate the inflammation medium, toxin and lots of middle and small molecule materials in the body of multiple organ function obstacle complex symptom (MODS) patient, and uses a lung membrane oxygen generator to replace the air exchange function of lung, to be used in reversal breath exhaustion, and uses albumin circulate purification treatment to completely eliminate the protein combine toxin and soluble small molecule toxin (as blood ammonia) of lung exhaustion patient, and accurately release water slowly. The invention can combine the support functions of lung, heart, kidney and liver, based on present clinic test and technique, with wide application.
Owner:SWS HEMODIALYSIS CARE CO LTD
Anti-fatigue cyclohexenone compounds from antrodia camphorata
InactiveUS7468392B1Facilitate creating phosphate kinase (CPK)Eliminate the muscle cell impairmentBiocideOrganic chemistryCyclohexenoneBlood ammonia
The present invention relates to a compound of Antrodia camphorata used to delay physiological fatigue, in particular to a extract isolated from Antrodia camphorata, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6-10-trienyl)-cyclohex-2-enone, and its use in delaying fatigue. Immediate supplementation of the compound according to the invention after high intensity exhausted exercise at 80% VO2max can promote the metabolism of creatine phosphate kinase and blood ammonia in human bodies, be beneficial to their recovery, further achieves the function in delaying physiological fatigue.
Owner:GOLDEN BIOTECH
Rapid small volume detection of blood ammonia
ActiveUS20150226702A1Facilitate and hasten leaving bloodSmall and convenient to useWeather/light/corrosion resistanceVolume/mass flow measurementPower flowBlood ammonia
A method for measuring ammonia in a blood sample may involve positioning the blood sample in proximity with an ammonia gas sensor, generating a current with the ammonia gas sensor in response to ammonia gas released from the blood sample, and measuring the current generated by the ammonia gas sensor, using a current measurement member coupled with the ammonia gas sensor. A device for measuring an ammonia level in a blood sample may include a blood sample containment member, an ammonia gas sensor coupled with the blood sample containment member, and a current measurement member coupled with the ammonia gas sensor. The method and device may be used to measure an ammonia level in a blood sample as small as one drop of blood, or approximately 0.05 mL of blood.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Blood ammonia reagent kit for enzyme detection
The reagent kit for enzyme detection of blood ammonia consists of tromethamine in 50-150 mmol, Tween-20 in 0.1-2 ml, sodium azide om 0.5-2 g, lactose in 5-50 g, glutamate dehydrogenase in 500-1500 u, alpha-ketoglutaric acid in 2-20 mmol, sodium acetonate in 1-10 mmol, and reducing nicotin-amide-adenine dinuclectide phosphate in 0.1-0.5 mmol. After regulating pH to optimal value of 8.0, the components are dissolved, packed and freeze dried and may be cold stored for two years. After being re-dissolved, the components are stabilized at room temperature for 1 week and cold stored to stabilize for 1 month. The reagent kit has powerful interference resistance, medium hemolysis and chylemia, blood sugar below 20 mmol / L, bilirubin below 0.1 mmol / L, enzyme activity loss less than 5 %, MADPH loss less than 10 %, linearity reaching 0.2 mmol / L, CV inside batch of 3.8 % and CV between batches of 5.1 %, and recovering rate of 96.1 %.
Owner:HARBIN MEDICAL UNIVERSITY
Compound amino acid injection for treating hepatic encephalopathy
ActiveCN101332209BIncrease parts by weightCorrect anomaliesOrganic active ingredientsNervous disorderSulfur amino acidBlood ammonia
The present invention provides a compound amino acid injection with high Fischer rate for curing hepatic encephalopathy, which can rapidly lower the blood ammonia density. The present invention increases the weight parts of three branched amino acid and arginine and reduces the weight parts of sulfur amino acid and ammonia amino acid. The injection provided by the present invention is more conducive to regulating the plasma amino acid spectrum to be normal, increases the density of arginine, stably lowers the level of blood ammonia of the patient and improves the immunity of the organism, thus achieving the aim of rapidly improving the symptom of hepatic encephalopathy and replenishing nutrition. Therefore, the injection of the present invention has higher curing effect in improving hepatic encephalopathy.
Owner:MITSUBISHI PHARMA GUANGZHOU
Anti-aging probiotics
PendingCN111248442ADelay lactic acid concentrationImprove actual functionsAntipyreticFrozen sweetsBiotechnologyInflammatory factors
The invention discloses anti-aging probiotics, and belongs to the field of all related food industries of probiotics. The anti-aging probiotics comprise lactobacillus paracasei combined melon powder.The effective amount of the lactobacillus paracasei combined melon powder is 10-60 billion per day for supplement, namely 10<10> cfu / day-6*10<10> cfu / day of lactobacillus paracasei and 1.2-2.6 g of melon powder per day. According to the method for using the lactobacillus paracasei combined melon powder as a food supplement or medicine for resisting oxidation stress and delaying aging, the lactobacillus paracasei combined melon powder is used to prepare a composition for improving body composition, improving body function or reducing fatigue after exercise. When being used as a food supplementor medicine for improving oxidation stress in the environment and for sports training, the composition has the advantages of not containing animal allergen, and can achieve the effects of improving expression of antioxidant and anti-inflammatory factors, delaying aging, relaxing mood, increasing muscle endurance, reducing lactic acid concentration and blood ammonia concentration in blood after sports, and the like.
Owner:上海泓商生物科技有限公司
Slow-release preparation of ornithine aspartate and preparation process thereof
ActiveCN103705490AWell mixedGood sustained releaseOrganic active ingredientsNervous disorderHepatic comaHepatic inflammation
Owner:BENGBU BBCA MEDICINE SCI DEV
Novel Anti-fatigue cyclohexenone compounds from antrodia camphorata
InactiveUS20080312474A1Facilitate creatine phosphate kinase (CPK) andEliminate the muscle cell impairmentBiocideOrganic chemistryCyclohexenonePhysiology
The present invention relates to a compound of Antrodia camphorata used to delay physiological fatigue, in particular to a extract isolated from Antrodia camphorata4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone, and its use in delaying fatigue. Immediate supplementation of the compound according to the invention after high intensity exhausted exercise at 80%VO2max can promote the metabolism of creatine phosphate kinase and blood ammonia in human bodies, be beneficial to their recovery, further achieves the function in delaying physiological fatigue.
Owner:GOLDEN BIOTECH
Multiple organ dysfunction support system
ActiveCN100486651CRemove inflammatory mediatorsEliminate endotoxinOther blood circulation devicesDialysis systemsOrgan dysfunctionOxygen
Owner:SWS HEMODIALYSIS CARE CO LTD
Determination of blood ammonia content and blood ammonia diagnostic reagent kit
InactiveCN1778946AStrong specificityImprove test accuracyMicrobiological testing/measurementPhosphoenolpyruvate carboxylaseGlutamate decarboxylase
The invention is about a method of measuring the content of blood ammonia, and it also concerns the reagent box of blood ammonia diagnosis. This invention belongs to the field of medical testing and measuring technology. The reagent box is consisted of buffer solution, 2ú¡ketoglutarate, reduced coenzyme, phosphoenolpyruvate, glutamate dehydrogenase, glutamate decarboxylase, phosphoenolpyruvate carboxylase, malate dehydrogenase and stabilizer. Firstly, we cause an enzyme-coupled reaction through mixing the sample and the reagent according to a certain proportion of volume; secondly, put the final reactant under the biochemical analyzer and test the absorbance variational situation (speed) of dominant wavelength; then we can get the content ofblood ammonia. By using this invention, we can get the necessary measuring result with high sensitiveness and fine precision through biochemical analyzer, and the result would not be contaminated by material of internal and exogenous sources. Thus, this method can be conveniently promoted and applied.
Owner:SUZHOU ANJ BIOTECHNOLOGY CO LTD
Blood ammonia determination and kit thereof
InactiveCN1746677AStrong specificityLess susceptible to interferenceColor/spectral properties measurementsBiological testingBlood ammoniaLength wave
A diagnostic kit of blood ammonia consists of buffer solution, 2 ¿C ketoglutarate, reduced coenzyme, glutamate dehydrogenase and stabilizer. Its measuring method includes mixing sample with reagent in certain volume ratio to let them generate enzyme couple reaction, placing reacted matter under biochemical analyzer for detecting absorbance variation of main wavelength so as to measure and calculating out content of blood ammonia.
Owner:SUZHOU ANJ BIOTECHNOLOGY CO LTD
Composition for detoxifying stomach and intestine and losing weight and application thereof
InactiveCN112826872AEnsure normal dischargeReduce absorptionOrganic active ingredientsMetabolism disorderBiotechnologyCellulose
The invention belongs to the technical field of health food and biological medicine, and particularly relates to a composition for detoxifying stomach and intestine and losing weight and application of the composition. The composition provided by the invention comprises three or any two of the following three components: cellulose, grease and adsorbents, wherein the components in the composition are mixed, excipients and additives are added to prepare capsules, pills, tablets, granules, suspensions, jellies, beverages and the like, and the composition can be used as common food, health-care food and / or medicine, and can promote human bodies to discharge various harmful toxicants, such as harmful microorganisms, heavy metals, harmful gases, harmful organic matters and inorganic matters, cancerogens and the like in gastrointestinal tracts; The composition is beneficial for improving sleep, low emotion, acne, chloasma, cyasma, skin itch, constipation, less defecation, diarrhea, wet, stink and itching anus, intestinal flatulence and too much fart, stinky fart and excrement, and reducing blood ammonia, and can be used for obese people and has a weight-losing effect.
Owner:NITEN (GUANGZHOU) BIOTECHNOLOGY CO LTD
Sleep aiding health product and preparation method thereof
The invention discloses a sleep aiding health product and a preparation method thereof. The sleep aiding health product is characterized by being prepared from the following ingredients in percentage by weight: 80% of gamma aminobutyric acid and 20% of spine date seed saponin. The preparation method comprises preparation steps as following: 1, preparation of the gamma aminobutyric acid; 2, preparation of the sleep aiding health product. The sleep aiding health product has the beneficial effects of calming nerves, resisting anxiety, reducing blood pressure and promoting growth hormone secretion of children, plays a nutritious role in a development process of the nervous system, has remarkable improvement effect on various symptoms such as Parkinson's disease, senile dementia, neurasthenia and the like, and can effectively reduce blood ammonia; the ingredient gamma aminobutyric acid contained in the sleep aiding health product further has functions of preventing skin aging, eliminating body odor, improving lipid metabolism, preventing arteriosclerosis, efficiently reducing weight and the like.
Owner:山东水晶生物科技股份有限公司
Measurement method of ammonia content in serum
InactiveCN103543117AImprove stabilitySolve the need for lyophilizationPreparing sample for investigationColor/spectral properties measurementsBlood ammoniaFreeze-drying
The invention discloses a method for measuring ammonia content in serum and namely discloses a dual reagent for measuring ammonia content in serum. Accelerated destruction tests of the reagent at 37 DEG C and 42 DEG C show that the reagent is good in stability, so that the complex problem that a freeze-drying agent needs freeze-drying and re-dissolving is solved; the reagent can be prepared when being used; the reagent is capable of stabilizing for 20 months at 2-8 DEG C. Clinical correlation tests show that the method is stable in measurement value, high in accuracy, applicable to manual, semi-automatic and automatic detection systems, and easy to popularize and apply.
Owner:DALIAN CITY SHAHEKOU DISTRICT SMALL MEDIUM & MICRO ENTERPRISES SERVICE CENT
Novel aceglutamide compound and pharmaceutical composition thereof
ActiveCN103012192AImprove stabilityLower blood ammoniaOrganic active ingredientsPowder deliveryBlood ammoniaHigh humidity
The invention discloses a novel aceglutamide compound. The purity of the compound is greater than 99.6%. At the same time, the invention further discloses a pharmaceutical composition of the novel aceglutamide compound. The composition comprises the following components in parts by weight: 90-600 parts of aceglutamide, 6-40 parts of alliin, 1-8 parts of mannitol, 0.8-5 parts of disodium hydrogen phosphate and 0.5-3 parts of sodium dihydrogen phosphate. In the pharmaceutical composition of the novel aceglutamide compound disclosed by the invention, the synergistic effect is generated among the mannitol, the disodium hydrogen phosphate and the sodium dihydrogen phosphate, so that the stability of the composition under high temperature, high humidity and bright light is enhanced; and the aceglutamide and the alliin mutually take synergistic effect and can play a role of observably reducing blood ammonia.
Owner:东台海滨科技创业园管理有限公司
Remedies for hyperammonemia
InactiveUS6852707B1Reduce ammonia levelsOrganic active ingredientsBacteriaDiabetes mellitusSide effect
By using xylobiose or xylooligosaccharide containing xylobiose as a main ingredient in place of lactulose, there is provided a blood ammonia lowering agent, a therapeutic agent of hyperammonemia or a therapeutic agent of hepatic encephalopathy that need be adminstered in smaller doses and which have no concern over side effects.Lactulose conventionally used as such drugs has to be administered in high doses and involves a safety problem when administered to patients with galactosemia or diabetes mellitus. The drug of the invention which contains xylobiose as a main ingredient solves these problems.
Owner:SUNTORY HLDG LTD
Determination of blood ammonia content and blood ammonia diagnostic reagent kit
InactiveCN1778937AStrong specificityLess susceptible to interferenceMicrobiological testing/measurementAbsorbanceMedical testing
The invention is about a method of measuring the content of blood ammonia, and it also concerns the reagent box of blood ammonia diagnosis. This invention belongs to the field of medical testing and measuring technology. The reagent box is consisted of buffer solution, glutamate, 2ú¡ketoglutarate, reduced coenzyme, adenosine triphosphate, glutamine synthetase, glutamate synthetase and stabilizer. Firstly, we cause an enzyme-coupled reaction through mixing the sample and the reagent according to a certain proportion of volume; secondly, put the final reactant under the biochemical analyzer and test the absorbance variational situation (speed) of dominant wavelength; then we can get the content of blood ammonia. By using this invention, we can get the necessary measuring result with high sensitiveness and fine precision through biochemical analyzer, and the result would not be contaminated by material of internal and exogenous sources. Thus, this method can be conveniently promoted and applied.
Owner:SUZHOU ANJ BIOTECHNOLOGY CO LTD
Liquid monomer reagent for determining content of ammonia in blood serum, preparation method and application thereof
InactiveCN102994612AGuaranteed stabilityGuaranteed accuracyMicrobiological testing/measurementSemi automaticActivity ratios
The invention discloses a liquid monomer reagent for determining the content of ammonia in blood serum, a preparation method and an application thereof. The liquid monomer reagent comprises the following components: buffering solution, glutamate dehydrogenase, alpha-oxoglutarate, reduction type nicotinamide adenine dinucleotide, glucose, glucose dehydrogenase and a stabilizing agent, wherein the enzyme activity ratio of the glutamate dehydrogenase and the glucose dehydrogenase is (3-3000):1. Shown by accelerating destruction test at the temperature of 37 DEG C and 42 DEG C, the blood-ammonia liquid monomer reagent is good in stability, solves the fussy problem that a lyophilized agent needs to be lyophilized and redissolved, can be prepared and used at any time, and can be stable for 18 mouths at the temperature of 2-8 DEG C; and shown by clinic correlation test, the liquid monomer reagent is stable in blood-ammonia determination, is high in determined-value accuracy, is applicable to manual, semi-automatic and automatic detection system and is easily promoted and used in all hospitals.
Owner:BEIJING LEADMAN BIOCHEM
Local-cock breeding method
The invention belongs to the technical field of chicken breeding, and particularly discloses a local-cock breeding method. The local-cock breeding method includes the following specific steps of (1) site selection and construction of chicken farms; (2) daily feeding of feed; (3) regular nutritional supplement. According to the local-cock breeding method, the disease resisting immunity of cocks is enhanced, movement is agile, vision is good, skeletons are robust, feathers are full, the chicken is thin in skin, tender in meat, small in fat amount and bright in color and does not taste greasy during long-time chewing, eaters are effectively prevented from getting fat after eating, ammonia metabolism is effectively promoted, the blood ammonia concentration is reduced, the liver is protected, the disease-resistant, antibacterial and anti-stress capacities of the cocks are improved, gastrointestinal tract wriggling is promoted, growth and reproduction of probiotics of gastrointestinal tracts are promoted, various nutrient substances can be smoothly decomposed, the nutrition conversion efficiency is improved, growth of the cocks is quickened accordingly, and the nutrient content of the meat quality is increased.
Owner:蚌埠农兴现代农业专业合作社
Acylated derivative for ornithine and aspartate dipeptide compound and application thereof
ActiveCN107619428ALower blood ammonia levelsQuick effectNervous disorderDipeptide ingredientsRat liverDipeptide
The invention provides an acylated derivative for an ornithine and aspartate dipeptide compound or an officinal salt thereof, a preparation method thereof, a medicine composition containing the derivative or the officinal salt thereof, and the application of the derivative or the officinal salt thereof for preparing medicines for preventing or curing hyperammonemia or liver diseases, particularlyhepatic encephalopathy. Experimental results definitely indicate that the concentration of blood ammonia can be obviously reduced after administration for the acylated derivative for the ornithine andaspartate dipeptide compound, the acylated derivative takes effect quickly by preferably compared with LOLA, subsequent dysmnesia after TAA-induced rat liver injury can be obviously improved, and theacylated derivative for the dipeptide has a certain treatment effect on hyperammonemia or liver diseases, particularly hepatic encephalopathy.
Owner:NANJING YOUKE BIOLOGICAL MEDICAL RES +3
Method for evaluating temperature and humidity state of environment where nursery pig individuals grow through blood biochemical indexes
The invention discloses a method for evaluating the temperature and humidity state of the environment where nursery pig individuals grow through blood biochemical indexes. According to the method, thetemperature and humidity state of the environment where nursery pig individual growth is located is evaluated comprehensively by quantitatively detecting the following biochemical indexes in nurserypig blood at the same time: albumin, glutamic-pyruvic transaminase, glutamic oxalacetic transaminase, blood urea nitrogen, creatinine, glucose, triglyceride, total cholesterol, creatine kinase, C reactive protein, lactic acid, blood ammonia and immunoglobulin M.
Owner:INST OF SUBTROPICAL AGRI CHINESE ACAD OF SCI
Antrodia camphorate pimelie kelone compounds for releasing physiological fatigue
InactiveCN101333156AAvoid damageImprove central fatigueOrganic active ingredientsFungi medical ingredientsBlood ammoniaCreatine kinase
The invention relates to an Antrodia cinnamomea compound which can slow down physiological fatigue, in particular to a 4-hydroxy -2,3-dimethoxy-6-methy-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone separated from the extract of Antrodia cinnamomea, which can effectively slow down the physiological fatigue. In the invention, after 80% of maximal oxygen uptake of high-intensity exhausted exercises, the application of the compound can promote the metabolism of creatine kinase and blood ammonia in the body and contribute to the restoration of the concentration to achieve the effect of slowing down the physical fatigue.
Owner:GOLDEN BIOTECH
Use of rhein in preparation of drugs for prevention and treatment of hepatic encephalopathy
InactiveCN109223748ALower blood ammoniaReduce inflammationOrganic active ingredientsNervous disorderInjury brainLiver necrosis
The invention relates to the technical field of medicine, in particular to the use of rhein in the preparation of drugs for prevention and treatment of hepatic encephalopathy. The application of rheinin the preparation of drugs for preventing and treating hepatic encephalopathy is disclosed for the first time. The model of hepatic encephalopathy induced by thioacetamide (TAA) and carbon tetrachloride (CCL4) was tested repeatedly. The results showed that rhein could reduce blood ammonia, alleviate inflammation of liver and brain tissue, protect liver function, reduce liver necrosis and improveliver injury and brain injury. Therefore, rhein or its salts can be used to prepare drugs for the prevention and treatment of hepatic encephalopathy. Rhein or its salts can be used as active ingredients to prevent and cure hepatic encephalopathy, which has the advantages of obvious effect, less dosage and quick onset.
Owner:SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
Anti-fatigue and sports probiotic
PendingCN111296843AIncrease glycogen contentReduce hoardingFood ingredient functionsBiotechnologyMuscle tissue
The invention discloses an anti-fatigue and sports probiotic, and belongs to the field of probiotic-related foods. The anti-fatigue and sports probiotic comprises bifidobacterium longum and BCAA, wherein the effective amount of the bifidobacterium longum combined with the BCAA is supplemented by 5 billion to 50 billion per a day, namely 5 * 109cfu / day to 5 * 1010cfu / day, and 3.2g to 4.6g of BCAA per day. The invention mainly provides application of the bifidobacterium longum combined with the BCAA in preparation of a composition for improving body composition, improving body function or reducing fatigue after sports; the improvement of the body composition comprises increasing muscle mass or reducing fat accumulation; the improvement of the body function system comprises improving athleticability; the athletic ability comprises muscle strength and muscle endurance; the reduction of the fatigue coefficient after sports is also to reduce injury or inflammation between muscle tissues after sports; the increase of the tissue glucose content after sports or the reduction of muscle injury; and the reduction of the lactic acid concentration, blood ammonia concentration or creatine phosphokinase activity in blood after sports.
Owner:上海泓商生物科技有限公司
Application of lycium barbarum polysaccharide in preparation of drugs for reducing blood ammonia and drugs for treating hepatic encephalopathy
InactiveCN105596359AQuick effectImprove securityOrganic active ingredientsNervous disorderBlood ammoniaHepatic encephalopathy
The present invention relates to the field of medicines, particularly relates to new application of lycium barbarum polysaccharide, and provides application of lycium barbarum polysaccharide in preparation of drugs for reducing blood ammonia and drugs for treating hepatic encephalopathy. Experiments proof that the lycium barbarum polysaccharide can increase the survival rate of mice with hepatic encephalopathy model mice, and the lycium barbarum polysaccharide can reduce the extent of liver injury in the model mice. The lycium barbarum polysaccharide used in treating of hepatic encephalopathy is rapid in effect and good in security.
Owner:JINAN UNIVERSITY
Derivatization gas chromatography-mass spectrometry method for detecting ammonia content of biological sample
The invention discloses a derivatization gas chromatographic-mass spectrometric method for detecting the ammonia content of a biological sample. The method includes the steps: (1) detection condition;(2) sample treatment; (3) atlas analysis; (4) standard blood ammonia sample preparation; (5) content calculation. By a pre-column derivatization gas chromatography-mass spectrometry method, the ammonia content of the biological sample can be detected in a targeted manner, the method supplements a clinical examination blood ammonia spectrometry method, and the influence of examination blood coagulation conditions and hemolysis on detection results can be effectively reduced. Detection sensitivity is improved, detection steps are greatly simplified, and time and cost are saved.
Owner:中国医科大学
Method for detecting blood ammonia content and blood ammonia diagnostic reagent kit
InactiveCN1749754AStrong specificityEasy to operateColor/spectral properties measurementsBiological testingPhosphoenolpyruvate carboxylaseAdenosine
The present invention belongs to the field of medical detection technology. The reagent kit for blood ammonia diagnosis includes buffering solution, adenosine triphophate, glutamic acid, pyruvic acid, phosphoenolpyruvic acid, reduced coenzyme, glutamine synthetase, pyruvate oxidase, phosphoenolpyruvate carboxylase, malate dehydrogenase and stabilizer. Through mixing the sample and reagent in certain volume ratio to produce enzyme coupling reaction, and detecting in biochemical analyzer the main wavelength absorbency change speed, the blood ammonia content is measured. The present invention can obtain the measurement result in biochemical analyzer in high sensitivity, high precision and no contamination of various foreign and internal matters.
Owner:王尔中
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com